Cyp3a Inducers + Osimertinib Interaction
Majorinteraction on record
Description
Co-administration decreases osimertinib exposure, potentially reducing efficacy. Avoid concomitant use or increase osimertinib dose to 160 mg daily if unavoidable.
Mechanism
CYP3A4-mediated induction decreases osimertinib exposure
Source: NLP:osimertinib